Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Inhibition of COX-2 with NS-398 prolongs allogeneic cardiac graft survival

Aug. 28, 2002

Bimosiamose prolongs rat kidney allograft survival by reducing intragraft cytokine production

Aug. 28, 2002

CD45RB MAb prolongs allograft survival in mice

Aug. 28, 2002

IL-10 gene therapy prevents recurrence of autoimmune diabetes after islet transplantation

Aug. 28, 2002

Ishihara Sangyo describes new inhibitors of Th1 and/or Th2 cytokine production

Aug. 26, 2002

HGF, a rapid diagnostic marker and preventative treatment for acute renal rejection

Aug. 23, 2002

New cathepsin S inhibitors designed by Boehringer Ingelheim researchers

Aug. 21, 2002

Wyeth scientists identify novel inhibitors of B7.1-CD28 interaction

Aug. 21, 2002

CAT and Xerion enter allergy target research collaboration

Aug. 21, 2002

ProdiGene and NIAID to begin phase I trial of oral traveler's diarrhea vaccine

Aug. 20, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....